Chipps Bradley E, Szefler Stanley J, Simons F Estelle R, Haselkorn Tmirah, Mink David R, Deniz Yamo, Lee June H
Capital Allergy and Respiratory Disease Center, Sacramento, CA 95819, USA.
J Allergy Clin Immunol. 2007 May;119(5):1156-63. doi: 10.1016/j.jaci.2006.12.668. Epub 2007 Mar 30.
Young patients with severe or difficult-to-treat asthma are an understudied population.
To assess age-associated and gender-associated differences in children and adolescents in the observational study, The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens.
Cross-sectional baseline data for patients greater than or equal to 6 years and less than or equal to 17 years (n = 1261) were stratified by age group (6-8, 9-11, 12-14, and 15-17 years). The chi(2) test for categorical variables and analysis of variance for continuous variables were used to identify differences among age groups, stratified by gender.
Most patients had moderate (55%) or severe (41%) asthma by physician assessment. Of those using greater than or equal to 3 long-term controllers (62%), 53% of children (6-11 years) and 44% of adolescents (12-17 years) reported an oral corticosteroid burst and 25% and 19%, respectively, had an emergency department visit in the previous 3 months; 10% and 15%, respectively, reported past intubation. In females, weight for age ranged between the 67th and 70th percentiles; height for age was between the 42nd and 54th percentiles (P < .01 among age groups). Lung function was lower in adolescents than children: prebronchodilator percent predicted forced expiratory volume in 1 second (FEV(1))/forced vital capacity was 0.92 (6-8 years) and 0.83 (15-17 years), P less than .05, in males; and 0.94 (6-8 years) and 0.87 (15-17 years), P less than .05, in females.
Children and adolescents demonstrated high rates of health care use and loss of lung function, despite using multiple long-term controllers.
Asthma treatments that prevent loss of lung function and reduce health care resource use are needed in young patients with severe or difficult-to-treat asthma.
患有重度或难治性哮喘的年轻患者是一个研究不足的群体。
在观察性研究“哮喘的流行病学和自然史:结局与治疗方案”中,评估儿童和青少年中与年龄和性别相关的差异。
将年龄大于或等于6岁且小于或等于17岁(n = 1261)患者的横断面基线数据按年龄组(6 - 8岁、9 - 11岁、12 - 14岁和15 - 17岁)分层。使用分类变量的卡方检验和连续变量的方差分析来确定按性别分层的年龄组之间的差异。
根据医生评估,大多数患者患有中度(55%)或重度(41%)哮喘。在使用至少3种长期控制药物的患者中(62%),53%的儿童(6 - 11岁)和44%的青少年(12 - 17岁)报告曾口服糖皮质激素冲击治疗,且在前3个月内分别有25%和19%的患者到急诊科就诊;分别有10%和15%的患者报告曾接受过插管治疗。女性的年龄别体重在第67至70百分位之间;年龄别身高在第42至54百分位之间(各年龄组间P <.01)。青少年的肺功能低于儿童:男性中,支气管扩张剂使用前1秒用力呼气容积(FEV₁)/用力肺活量预测值百分比在6 - 8岁时为0.92,在15 - 17岁时为0.83,P <.05;女性中分别为0.94(6 - 8岁)和0.87(15 - 17岁),P <.05。
尽管使用了多种长期控制药物,但儿童和青少年的医疗保健利用率和肺功能丧失率仍很高。
对于患有重度或难治性哮喘的年轻患者,需要有能预防肺功能丧失并减少医疗保健资源使用的哮喘治疗方法。